Related Experiment Video
Updated: Jul 2, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Decoding of the Role of TREM2 in Neuropathic Pain: Molecular Pathway and Neuroinflammatory Mechanism
Nithya Vijayan1, Punniyakoti Veeraveedu Thanikachalam2, Saraswati Patel1
1Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha College of Pharmacy, Chennai, India.
Abstract:
Neuropathic pain is a debilitating condition characterized by chronic pain that is often refractory to conventional treatments. Increasing evidence suggests that microglia, the resident immune cells of the central nervous system, play a crucial role in modulating pain pathways through neuroinflammatory mechanisms. The Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), in conjunction with DNAX-activating protein 12 (DAP12), regulates microglial activation and immune responses, thereby influencing neuropathic pain progression. This review explores the molecular mechanisms by which TREM2 contributes to pain modulation, focusing on its role in microglial activation, cytokine release, oxidative stress, and neuronal sensitization. Furthermore, we discuss the therapeutic potential of targeting TREM2 signaling for neuropathic pain management. Understanding the interplay between TREM2 and neuroinflammation offer novel insights into developing targeted interventions for chronic pain conditions.
Insights
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) influences neuropathic pain by regulating microglia activation and neuroinflammation. Targeting TREM2 signaling offers potential for novel chronic pain management strategies.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Neuropathic pain is a chronic pain condition often resistant to standard treatments.
- Microglia, the central nervous system's immune cells, are increasingly recognized for their role in pain modulation via neuroinflammation.
- The TREM2-DAP12 pathway is critical for regulating microglial function and immune responses.
Purpose of the Study:
- To review the molecular mechanisms of TREM2 in neuropathic pain.
- To explore TREM2's role in microglial activation, cytokine release, oxidative stress, and neuronal sensitization.
- To discuss the therapeutic potential of targeting TREM2 for neuropathic pain.
Main Methods:
- Literature review focusing on TREM2 signaling in neuropathic pain models.
- Analysis of studies investigating microglial activation and neuroinflammatory mediators.
- Examination of research on TREM2's impact on neuronal function and pain signaling.
Main Results:
- TREM2 signaling is a key regulator of microglial activation in neuropathic pain.
- TREM2 influences the release of pro-inflammatory cytokines and oxidative stress markers.
- Dysregulation of TREM2 contributes to neuronal sensitization and heightened pain perception.
Conclusions:
- TREM2 plays a significant role in the neuroinflammatory processes underlying neuropathic pain.
- Targeting TREM2-DAP12 signaling presents a promising therapeutic avenue for managing chronic pain.
- Further research into TREM2 pathways could yield novel interventions for neuropathic pain.
Related Concept Videos
Analgesia and Pain Management
Nociception
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Excitatory and Inhibitory Effects of Neurotransmitters
Major Somatic Sensory Pathways